GlassScriptPhysician profile
Tomika Coleman
NPI 1013272699
$2,882.60
in general payments reported to CMS, 2019-2025
8 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,423 · 2023: $155 · 2024: $128 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,422.80 | 2022 | |
| Organogenesis INC. | $170.84 | 2023-2024 | Apligraf, Cygnus Dual |
| Abbott Laboratories | $131.77 | 2025 | Esprit, Proclaim |
| Smith+Nephew, INC. | $70.42 | 2023-2024 | Collagenase Santyl |
| Tactile Systems Technology INC | $30.51 | 2025 | Flexitouch Plus, Nimbl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.92 | 2024 | Arazlo |
| Musculoskeletal Transplant Foundation INC. | $19.93 | 2024 | |
| Curonix LLC | $15.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomika Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.